Nuevas
convocatorias 7PM Salud
La Comisión Europea ha publicado, con fecha 20 de julio
de 2010, dos convocatorias del tema “Salud” del programa de
Cooperación del Séptimo Programa Marco europeo de I+D.
Estas
convocatorias pertenecen al
Programa de Trabajo 2011
(http://cordis.europa.eu/fp7/wp-2011_en.html).
La información completa de cada convocatoria la encontrareis
haciendo clic en el código respectivo. Si tenéis problemas
de acceso con el enlace, podéis cortar y pegar la dirección
completa en vuestro navegador. l
Los plazos de presentación de propuestas finalizan en los
días señalados a las 17 horas (hora local de Bruselas)
PROGRAMA ESPECÍFICO DE COOPERACIÓN
Tema: Salud
FP7-HEALTH-2011-single-stage
http://cordis.europa.eu/fp7/dc/index.cfm?fuseaction=UserSite.CooperationDetailsCallPage&call_id=323#infopack
Presupuesto indicativo: 160.500.000 euros
Fecha límite: 10 de noviembre de 2010
Temes convocados:
1.BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES
FOR HUMAN HEALTH. 1.1 HIGH-THROUGHPUT RESEARCH,
1.1-3: Highthroughput proteomics for human health and
disease.
1.4 INNOVATIVE THERAPEUTIC APPROACHES AND INTERVENTIONS.
1.4-4: High impact research initiative for better
immunisation. 1.4-5: New therapeutic approaches in chronic
inflammatory and autoimmune diseases.
2. TRANSLATING RESEARCH FOR HUMAN HEALTH.2.1.
INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA
GATHERING, SYSTEMS BIOLOGY. 2.1.1 Large-scale data
gathering. 2.1.1-1: High impact research initiative
on the human epigenome. 2.1.1-4: Population genetics studies
on cardio-metabolic disorders in EU/AC and EECA populations.
2.2. RESEARCH ON THE BRAIN AND RELATED DISEASES, HUMAN
DEVELOPMENT AND AGEING. 2.2.1. Brain and brain-related
diseases. 2.2.1-4: Creating clinical and molecular
tools for experimental therapy of paediatric
neurodegenerative disorders causing childhood dementia in
Europe and India.
2.3. TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES:
TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH. 2.3.1.
Anti-microbial drug resistance. 2.3.1-2:
Multidisciplinary research on the evolution and transfer of
antibiotic resistance. 2.3.1-3: Management of Gram negative
multi-drug resistant infections.
2.3.3. Potentially new and re-emerging epidemics.
2.3.3-2: Comprehensive control of Dengue fever under
changing climatic conditions.
2.4. TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES.
2.4.1. Cancer. 2.4.1-3: Epidemiology and
aetiology of infection-related cancers.
3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN
CITIZENS. 3.3 HEALTH PROMOTION. 3.3-3: Developing
and implementing methods for the transfer of research into
policy in the fields of health promotion and disease
prevention. 3.3-4: A road-map for mental health research in
Europe.
3.4 INTERNATIONAL PUBLIC HEALTH & HEALTH SYSTEMS.
3.4-1: Development and assessment of comprehensive and
integrated interventions and programmes to improve
reproductive health and health equity. 3.4-2: Building
sustainable capacity for research for health and its social
determinants in low and middle income countries. 3.4-3:
Multilateral cooperation between Europe, Africa and Latin
America on public health and health services research.
4. OTHER ACTIONS ACROSS THE HEALTH THEME. 4.1.
COORDINATION AND SUPPORT ACTIONS ACROSS THE THEME.
4.1-1: Networking of major research institutions to
coordinate communication actions aimed at the media and the
general public. 4.1-2: Targeting publication bias. 4.1-3:
Linking EU and Latin American policy making institutions in
the field of health research. 4.1-4: Organisation of
supporting actions and events related to the Presidency of
the European Union.
4.2. RESPONDING TO EU POLICY NEEDS. 4.2-1:
Investigatordriven clinical trials4 on off-patent medicines
for children. 4.2-2: Adverse drug reaction research. 4.2-3:
New methodologies for clinical trials5 in personalised
medicine.
Esquemas de financiación: diferentes según el tema,
consultad el texto completo de la convocatoria.
FP7-HEALTH-2011-two-stage
http://cordis.europa.eu/fp7/dc/index.cfm?fuseaction=UserSite.CooperationDetailsCallPage&call_id=324#infopack
Presupuesto indicativo: 498.000.000 euros
Fecha límite: 13 de octubre de 2010
Temas convocados:
1.BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES
FOR HUMAN HEALTH. 1.1 HIGH-THROUGHPUT RESEARCH.
1.1-1: SME-targeted research for developing tools and
technologies for high-throughput research. 1.1-2: Genome-based
biomarkers for patient stratification and pharmacogenomic
strategies. 1.4 INNOVATIVE THERAPEUTIC APPROACHES AND
INTERVENTIONS. 1.4-1: Regenerative medicine clinical
trials. 1.4-2: Tools, technologies and devices for
application in regenerative medicine. 1.4-3: Development and
production of new, high-affinity protein scaffolds for
therapeutic use.
2. TRANSLATING RESEARCH FOR HUMAN HEALTH. 2.1.
INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA
GATHERING, SYSTEMS BIOLOGY. 2.1.1 Large-scale data
gathering. 2.1.1-2: Proteins and their interactions
in health and disease. 2.1.1-3: Large scale genomics
approaches to identify host determinants of infectious
diseases. 2.2. RESEARCH ON THE BRAIN AND RELATED DISEASES,
HUMAN DEVELOPMENT AND AGEING. 2.2.1. Brain and
brain-related diseases. 2.2.1-1: Investigatordriven
clinical trials4 for childhood-onset neurodegenerative
diseases. 2.2.1-2: Understanding the role of
neuroinflammation in neurodegenerative diseases. 2.2.1-3:
Addictive and/or compulsive behaviour in children and
adolescents: translating pre-clinical results into therapies.
2.2.2. Human development and ageing. 2.2.2-1:
Investigatordriven clinical trials for therapeutic
interventions in elderly populations. 2.2.2-2: Linking human
development and ageing. 2.3. TRANSLATIONAL RESEARCH IN
MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO
PUBLIC HEALTH. 2.3.1. Anti-microbial drug
resistance. 2.3.1-1: Investigatordriven clinical
trials6 of off-patent antibiotics. 2.3.1-4: Development of
multi-analyte diagnostic tests. 2.3.1-5: Development of
tools to control microbial biofilms with relevance to
clinical drug resistance. 2.3.3. Potentially new and
re-emerging epidemics. 2.3.3-1: Identification of
factors promoting the emergence of pathogens with human
pandemic potential from pathogens with a zoonotic background
and related prevention strategies. 2.3.3-3: Development of
an evidence-based behavioural and communication package to
respond to major epidemic outbreaks. 2.4. TRANSLATIONAL
RESEARCH IN OTHER MAJOR DISEASES. 2.4.1. Cancer.
2.4.1-1: Investigatordriven treatment trials7 for rare
cancers. 2.4.1-2: Translational research on cancers with
poor prognosis. 2.4.2. Cardiovascular diseases.
2.4.2-1: Investigatordriven clinical trials8 for the
management of cardiovascular diseases. 2.4.2-2: Evaluation
and validation studies of clinically useful biomarkers in
prevention and management of cardiovascular diseases.
2.4.3. Diabetes and obesity. 2.4.3-1:
Investigatordriven clinical trials9 to reduce diabetes
complications. 2.4.3-2: Development of novel treatment
strategies based on knowledge of cellular dysfunction.
2.4.3-3: Molecular and physiological effects of lifestyle
factors on diabetes/obesity.2.4.3-4: Genetic and
environmental factors in obesity and/or diabetes in specific
populations.
3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN
CITIZENS. 3.3 HEALTH PROMOTION. 3.3-1:
Developing methodologies to reduce inequities in the
determinants of health. 3.3-2: Analysis of integrated
strategies for sustainable behaviour change.
Esquemas de financiación: diferentes según el tema,
consultad el texto completo de la convocatoria.
Para cualquier consulta, podéis contactar con Angeles
Sanchis, (ext. 51276,
operuv@uv.es).
Este mensaje se ha distribuido a la lista
EUROSALUT
(Oficina Proyectos Europeos UV). Para subscribirse, envíe un mensaje a la
dirección
listserv@listserv.uv.es con el texto siguiente: subscribe
EUROSALUT Nombre Apellidos. Para cancelar la subscripción,
envíe un mensaje a la dirección
listserv@listserv.uv.es< con el texto: signoff EUROSALUT.
